RYOZO UTAHARA
- Molecular Biology
- Pharmacology top 5%
- Organic Chemistry top 10%
- Molecular Medicine top 5%
- Infectious Diseases
- Co-authors
- Masanori OkanishiHAMAO UMEZAWAShinichi KondoKenji MaedaHitoshi UmezawaYoshirō OkamiSusumu MitsuhashiK Yagishita
- Topics
- Microbial Natural Products and Biosynthesis (8 papers)Chemical Synthesis and Analysis (5 papers)Biochemical and Molecular Research (3 papers)
- Partner nations
- JapanUnited States
In The Last Decade
RYOZO UTAHARA
26 papers receiving 557 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 371
- Pharmacology 228
- Organic Chemistry 160
- Molecular Medicine 131
- Infectious Diseases 69
Countries citing papers authored by RYOZO UTAHARA
This map shows the geographic impact of RYOZO UTAHARA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RYOZO UTAHARA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RYOZO UTAHARA more than expected).
Fields of papers citing papers by RYOZO UTAHARA
This network shows the impact of papers produced by RYOZO UTAHARA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RYOZO UTAHARA. The network helps show where RYOZO UTAHARA may publish in the future.
Co-authorship network of co-authors of RYOZO UTAHARA
This figure shows the co-authorship network connecting the top 25 collaborators of RYOZO UTAHARA. A scholar is included among the top collaborators of RYOZO UTAHARA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RYOZO UTAHARA. RYOZO UTAHARA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 16 | |
| 3 | 19 | |
| 4 | 53 | |
| 5 | 3 | |
| 6 | 53 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | Inactivation of aminoglycosidic antibiotics by resistatt organisms. | 1 |
| 10 | 1 | |
| 11 | 46 | |
| 12 | Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli. | 73 |
| 13 | 94 | |
| 14 | 13 | |
| 15 | A new source of fradicinmycelin like antifungal antibiotic. | 2 |
| 16 | Production and isolation of a new antibiotic: kanamycin. | 136 |
| 17 | A new antibiotic, ractinomycin. | 3 |
| 18 | Studies on the production of griseolutein. | 2 |
| 19 | Studies on anti-tumor substances produced by microorganisms. II. On the process of large scale production and chemical characters of the antitumor substance No. 289. | 3 |
| 20 | An antibiotic, phthiomycin. | 1 |
About RYOZO UTAHARA
RYOZO UTAHARA is a scholar working on Microbiology, Pharmacology and Molecular Medicine, having authored 26 papers that have together received 644 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), Chemical Synthesis and Analysis (5 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Molecular Medicine (131 citations), Pharmacology (228 citations) and Toxicology (22 citations). RYOZO UTAHARA has collaborated with scholars based in Japan and United States. Frequent co-authors include Masanori Okanishi, HAMAO UMEZAWA, Shinichi Kondo, Kenji Maeda, Hitoshi Umezawa, Yoshirō Okami, Susumu Mitsuhashi, K Yagishita, Kenji Maeda and Tsutomu Takeuchi. Their work appears in journals such as Science, Journal of Bacteriology and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.